ClinVar Miner

Submissions for variant NM_000238.4(KCNH2):c.2769_2771delinsAGC (p.Gly924Ala)

dbSNP: rs1800969882
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Color Diagnostics, LLC DBA Color Health RCV001843053 SCV001344589 uncertain significance Cardiac arrhythmia 2019-12-18 criteria provided, single submitter clinical testing This missense variant replaces glycine with alanine at codon 924 of the KCNH2 protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). Splice site prediction tools suggest that this variant may not impact RNA splicing. To our knowledge, functional studies have not been performed for this variant. This variant has been reported in an individual affected with epilepsy and sudden death (PMID: 26704558) and in an individual affected with sudden cardiac arrest (PMID: 29884292). A different DNA change (c.2771G>C) resulting in the same amino acid change as this variant has been reported in an individual referred for long QT syndrome genetic test (PMID: 19716085). This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.
Ambry Genetics RCV002436744 SCV002747182 uncertain significance Cardiovascular phenotype 2022-05-04 criteria provided, single submitter clinical testing The c.2769_2771delGGGinsAGC variant (also known as p.G924A), located in coding exon 12 of the KCNH2 gene, results from an in-frame deletion of GGG and insertion of AGC at nucleotide positions 2769 to 2771. This results in the substitution of the glycine residue for an alanine residue at codon 924, an amino acid with similar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be neutral by in silico analysis (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.